The size of the Oxygen Therapy Market in North America was worth USD 0.94 billion in 2020. It is further estimated to be growing at a CAGR of 5.51% and value USD 1.23 billion by 2025. Oxygen therapy involves administering oxygen through an external device.
The North-American oxygen therapy market's growth is mainly driven by a wide range of respiratory diseases and disorders caused by the high level of air pollution and poor lifestyle choices. These are primarily characterized by low oxygen levels in the body, which is also known as hypoxemia, which eventually leads to damage to tissue cells, causing shortness of breath, poor quality of life, and strain on the heart. An increasing number of government initiatives to raise awareness about the diseases and the treatments available for them has further aided the cause for the North American oxygen therapy market. Initiatives such as the National Asthma Education and Prevention Program (NAEPP), National Asthma Control Initiative (NACI) aim to offer result-oriented solutions for ensuring asthma control in the U.S.
This research report on the North American Oxygen Therapy Market has been segmented & sub-segmented into the following categories:
By Product Type:
Based on product type, the Oxygen source equipment segment is expected to grow at 11% CAGR. It is attributed to the consolidation of this equipment in the wide variety of uses as the first treatment line.
By Application:
Based on application, Chronic obstructive pulmonary disease holds the largest share of the application segment. It is anticipated to grow lucratively at a CAGR of over 10.5% over the next five years. This is due to the increasing popularity of supplemental administration in conjunction with first-line treatments available for COPD. Moreover, this treatment includes faster response rates, reliability, and portability, and above all, improves chances of survival.
By End-user:
Based on end-use, Home health care dominates the end-use segment, owing to the rise in the elderly population and the increasing number of patients with low mobility and long-term care requirements in conditions such as Alzheimer’s disease.
By Country:
Geographically, the U.S. is expected to lead the regional market due to rising COPD instances among its citizens. Technological advances and high awareness about the availability of treatment for several chronic respiratory diseases are expected to drive the market in the coming years.
This market is extremely disjointed with numerous big and developing players operating in the business. The major companies dominating the Oxygen Therapy Market in this region are Chart Industries Inc., Invacare Corporation, Becton, Dickinson and Company, Smiths Medical, Teleflex Incorporated, Inogen, DeVilbiss Healthcare, Essex Industries, Inc., Allied Healthcare Products Inc., and Respan Products Inc.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Oxygen Source Equipment
5.1.2.1 Oxygen Concentrators
5.1.2.1.1 Fixed Oxygen Concentrators
5.1.2.1.2 Portable Oxygen Concentrators
5.1.2.2 Liquid Oxygen Devices
5.1.2.3 Oxygen Cylinders
5.1.3 Oxygen Delivery Devices
5.1.3.1 Oxygen Masks
5.1.3.2 Nasal Cannulas
5.1.3.3 Venturi Masks
5.1.3.4 Non-Rebreather Masks
5.1.3.5 Bag Valve Masks
5.1.3.6 Other Devices
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Portability
5.2.1 Introduction
5.2.2 Stationary Oxygen Therapy Devices
5.2.3 Portable Oxygen Therapy Devices
5.2.4 Y-o-Y Growth Analysis, By Portability
5.2.5 Market Attractiveness Analysis, By Portability
5.2.6 Market Share Analysis, By Portability
5.3 Application
5.3.1 Introduction
5.3.2 Chronic Obstructive Pulmonary Disease
5.3.3 Asthma, Obstructive Sleep Apnea
5.3.4 Respiratory Distress Syndrome
5.3.5 Cystic Fibrosis
5.3.6 Pneumonia
5.3.7 Y-o-Y Growth Analysis, By Application
5.3.8 Market Attractiveness Analysis, By Application
5.3.9 Market Share Analysis, By Application
5.4 End User
5.4.1 Introduction
5.4.2 Home Care Settings
5.4.3 Hospitals
5.4.4 Ambulatory Surgical Centers & Physician Offices
5.4.5 Others
5.4.6 Y-o-Y Growth Analysis, By End User
5.4.7 Market Attractiveness Analysis, By End User
5.4.8 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Portability
6.1.3.4 By Application
6.1.3.5 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Portability
6.1.4.4 By Application
6.1.4.5 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Portability
6.1.5.4 By Application
6.1.5.5 By End User
6.2 United States
6.3 Canada
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Respironics Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Teleflex Incorporated
8.3 AirSep Corporation
8.4 DeVilbiss Healthcare
8.5 ResMed Inc
8.6 Fisher & Paykel Healthcare Limited
8.7 Invacare
8.8 Essex Industries Inc.
8.9 HERSILL S.L.
8.10 Weinmann Emergency Medical Technology
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
